I agree that this site is using cookies. You can find further informations here.
X
Lord, CJ
125  results:
Search for persons X
?
1

The genomic profile of HER2‐amplified breast cancers: the i..:

Marchiò, C ; Natrajan, R ; Shiu, KK...
The Journal of Pathology.  216 (2008)  4 - p. 399-407 , 2008
Link: https://doi.org/10.1002/..
 
?
2

The legal framework for more robust forensic science eviden..:

The Rt Hon. the Lord Thomas of Cwmgiedd ; Thomas, CJ Lord
Philosophical Transactions: Biological Sciences.  370 (2015)  1674 - p. 1-5 , 2015
Link: http://www.jstor.org/sta..
 
?
3

Practice Direction: Crown Office List (23 March 2000):

Bingham CJ, Lord
Judicial Review.  5 (2000)  2 - p. 79-79 , 2000
Link: https://doi.org/10.1080/..
 
?
4

Cancer-associated FBXW7 loss is synthetic lethal with pharm..:

Baxter, JS ; Brough, R ; Krastev, DB...
Molecular Oncology, 2023,.  , 2024
Link: https://repository.icr.a..
 
?
5

SMG8/SMG9 Heterodimer Loss Modulates SMG1 Kinase to Drive A..:

Llorca-Cardenosa, MJ ; Aronson, LI ; Krastev, DB...
709958.  , 2023
Link: https://repository.icr.a..
 
?
6

SF3B1 hotspot mutations confer sensitivity to PARP inhibiti..:

Bland, P ; Saville, H ; Wai, PT...
doi:10.1038/s41588-023-01460-5.  , 2023
Link: https://doi.org/10.1038/..
 
?
7

Systemic Therapy for Hereditary Breast Cancers:

Harvey-Jones, EJ ; Lord, CJ ; Tutt, ANJ
S0889-8588(22)00102-2.  , 2023
Link: https://repository.icr.a..
 
?
8

MND1 and PSMC3IP control PARP inhibitor sensitivity in mito..:

Zelceski, A ; Francica, P ; Lingg, L...
ARTN 112484.  , 2023
Link: https://repository.icr.a..
 
?
9

SF3B1 hotspot mutations confer sensitivity to PARP inhibiti..:

Bland, P ; Saville, H ; Wai, PT...
NATURE GENETICS.  , 2023
Link: https://qmro.qmul.ac.uk/..
 
?
10

A HUWE1 defect causes PARP inhibitor resistance by modulati..:

Pettitt, SJ ; Shao, N ; Zatreanu, D...
doi:10.1038/s41388-023-02782-8.  , 2023
Link: https://doi.org/10.1038/..
 
?
11

Identification of a Molecularly-Defined Subset of Breast an..:

Serra, V ; Wang, AT ; Castroviejo-Bermejo, M...
707431.  , 2022
Link: https://repository.icr.a..
 
?
12

The ubiquitin-dependent ATPase p97 removes cytotoxic trappe..:

Krastev, DB ; Li, S ; Sun, Y...
doi:10.1038/s41556-021-00807-6.  , 2022
Link: https://doi.org/10.1038/..
 
?
13

Resistance to DNA repair inhibitors in cancer:

Baxter, JS ; Zatreanu, D ; Pettitt, SJ.
Molecular Oncology, 2022,.  , 2022
Link: https://repository.icr.a..
 
?
14

Opinion: PARP inhibitors in cancer-what do we still need to..:

Wicks, AJ ; Krastev, DB ; Pettitt, SJ..
Open Biology, 2022, 12 (7), pp. 220118 -.  , 2022
Link: https://repository.icr.a..
 
?
15

ADP-ribosyltransferases, an update on function and nomencla..:

Lüscher, Bernhard ; Ahel, I ; Altmeyer, Matthias...
http://urn.nb.no/URN:NBN:no-93576.  , 2022
Link: http://hdl.handle.net/10..
 
1-15